{
    "doi": "https://doi.org/10.1182/blood.V124.21.5638.5638",
    "article_title": " Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)  ",
    "article_date": "December 6, 2014",
    "session_type": "641. CLL: Biology and Pathophysiology, excluding Therapy",
    "abstract_text": "Basis. Abnormalities in chromosome 8 (8p-/8q+) are observed in 2-5% of CLL patients. Microarray studies have revealed up to 30-40% of 8 alterations in del(17p) patients and an independent association with poor outcome. Large series assessing CLL patients with 8p-/8q+ are scarce. Aims. 1. To describe the frequency of 8q gains (8q+) and 8p losses (8p-) in CLL patients with del(17p); 2. To compare cytogenetic and clinical characteristics between patients with 8p-/8q+ (Alt-chr8) and those with normal chromosome 8 (N-chr8); 3. To assess their prognostic value. Patients and methods. From 2,249 patients included in the Spanish CLL database, 75 del(17p) cases were selected. Gains of MYC (8q24) and losses of LPL (8p22) were studied by FISH. Clinical and cytogenetic data of Alt-chr8 and N-chr8 were compared. Results. 8p- and/or 8q+ were found in 21/75 patients (28%). In the Alt-chr8 group, 8q+ was more frequent than 8p- (71% vs. 52%) and 29% showed concomitance of both abnormalities, suggesting the presence of i(8q). Six different FISH patterns were identified, some of them coexisting in the same patient (Table 1). Conventional cytogenetics data were available in 47 cases (15 Alt-chr8 and 32 N-chr8). Alt-chr8 group showed a higher median number of alterations and frequency of complex karyotypes (P=0.048 and P=0.013). In the Alt-chr8 group, the karyotype revealed 8p-/8q+ in 3 patients and in 9 cases with abnormal karyotype, the presence of marker chromosomes, added material and/or cryptic alterations would explain the FISH results (Table 1). From 66 cases, routine FISH data (13q, 12 and 11q) were available and no significant differences were detected among Alt-chr8 and N-chr8, as with other clinical and analytical parameters at diagnosis. Of note, shorter Overall Survival (OS) was observed for Alt-chr8, although differences were only significant for patients with 8p- (P=0.012, Figure 1 ). Interestingly, for 3 patients of Alt-chr8 group, previous non-del(17p) samples already presented 8p-/8q+. Conclusions. 1. In CLL patients with del(17p), detection of 8p- and/or 8q+ is associated with an increased karyotypic complexity and a worse outcome; 2. 8p-/8q+ could act as a primary event that trigger del(17p). More cases are required to confirm this hypothesis. Acknowledgments. PI11/01621; RD12/0036/0044, RD12/0036/0069; 2014/SGR585; Fundaci\u00f3 La Caixa. Table 1. Karyotypes and FISH results of patients with del(17p) and Alt-chr8.  . Conventional Cytogenetics . FISH . ID . Karyotype . % del(17p) . Chromosome 8 alteration . % . Pattern* . 1  46,XX,del(8)(p21),add(10)(q26),add(17)(p13),+2ac[5]/47,XX,+12,add(17)(p13),del(18)(q21),add(22)(q13)[3] 80 20 1O2G 8p-  2  -  95 75 3  46,XX,add(6)(q24),add(14)(q32,3),i(17)(q10)[6]/46,XX[8] 95 75 4  -  76 50 5  45,XY,-5,-9,-15,add(17)(p13),+18,-21,+2mar[13]/46,XY[37] 70 17 6  46,X,der(X),add(8)(p23),del(13)(q12q22),add(17)(p13)[11]/46,XX[13] 10 32 1O3G 8p- and 8q+  7  -  95 64 8  45,XY,add(3)(q29),del(4)(q26q35),der(7)(1p36-1p32::7p22-7q32::15q22-15q26), -8,der(9),del(13)(q21q34),-15,-17,-18,+19,add(19)(p13),+2mar,+ac[17]/46,XY[3] 78 34/21 1O3G/2O3G 9  44,X,-X,-6,der(13;15)(q10;q10),add(17)(p13),-20,+mar[13]/46,XX[7] 95 10/23 1O3G/1O2G 10  -  95 66/31 11  45,XY,add(6)(q22),del(11)(q11q22),-17[15]/44,XY,add(6)(q22),del(11)(q11q22),-17,-20,-22,+mar[2] 87 40/24 12  46,XX,del(13)(q14q21)[2]/45,X,-X,del(13)(q14q21)[3]/45,XX,add(3)(q27), t(9;10)(q21;q22),+12,der(12)t(12;17)(q11;p11),del(13)(q14q21),-14,-17[7]/46,XX[8] 70 62 2O3G  8q+  13  46,XY[30] 14 88 14  46,XY[13] 80 82 15  47,XY,+12[8]/46,XY,add(1)(p34),add(2)(q34),t(11;22)(p14;q11),+12,-22[15]/46,XY[11] 75 18 16  43,X,-X,del(2)(p15),+4,-7,add(11)(q21),-12,-13,add(14)(q32),add(17)(p11)[6]/46,XX[9] 19 14 17  45,XY,del(6)(q?),-9,add(14)(q32),-22,+mar[9]/ 46,XY,del(6)(q?),add(17)(p13),add(19)(q13)[21] 55 23 18  45,XY,add(6)(p11),-22[13]/46,XY,i(17)(q10)[5]/46,XY[16] 16 57 19  -  70 66 2O4G 20  -  90 81 2OnG 21  46,XY[11] 43 60 4O4G Tetraploid  . Conventional Cytogenetics . FISH . ID . Karyotype . % del(17p) . Chromosome 8 alteration . % . Pattern* . 1  46,XX,del(8)(p21),add(10)(q26),add(17)(p13),+2ac[5]/47,XX,+12,add(17)(p13),del(18)(q21),add(22)(q13)[3] 80 20 1O2G 8p-  2  -  95 75 3  46,XX,add(6)(q24),add(14)(q32,3),i(17)(q10)[6]/46,XX[8] 95 75 4  -  76 50 5  45,XY,-5,-9,-15,add(17)(p13),+18,-21,+2mar[13]/46,XY[37] 70 17 6  46,X,der(X),add(8)(p23),del(13)(q12q22),add(17)(p13)[11]/46,XX[13] 10 32 1O3G 8p- and 8q+  7  -  95 64 8  45,XY,add(3)(q29),del(4)(q26q35),der(7)(1p36-1p32::7p22-7q32::15q22-15q26), -8,der(9),del(13)(q21q34),-15,-17,-18,+19,add(19)(p13),+2mar,+ac[17]/46,XY[3] 78 34/21 1O3G/2O3G 9  44,X,-X,-6,der(13;15)(q10;q10),add(17)(p13),-20,+mar[13]/46,XX[7] 95 10/23 1O3G/1O2G 10  -  95 66/31 11  45,XY,add(6)(q22),del(11)(q11q22),-17[15]/44,XY,add(6)(q22),del(11)(q11q22),-17,-20,-22,+mar[2] 87 40/24 12  46,XX,del(13)(q14q21)[2]/45,X,-X,del(13)(q14q21)[3]/45,XX,add(3)(q27), t(9;10)(q21;q22),+12,der(12)t(12;17)(q11;p11),del(13)(q14q21),-14,-17[7]/46,XX[8] 70 62 2O3G  8q+  13  46,XY[30] 14 88 14  46,XY[13] 80 82 15  47,XY,+12[8]/46,XY,add(1)(p34),add(2)(q34),t(11;22)(p14;q11),+12,-22[15]/46,XY[11] 75 18 16  43,X,-X,del(2)(p15),+4,-7,add(11)(q21),-12,-13,add(14)(q32),add(17)(p11)[6]/46,XX[9] 19 14 17  45,XY,del(6)(q?),-9,add(14)(q32),-22,+mar[9]/ 46,XY,del(6)(q?),add(17)(p13),add(19)(q13)[21] 55 23 18  45,XY,add(6)(p11),-22[13]/46,XY,i(17)(q10)[5]/46,XY[16] 16 57 19  -  70 66 2O4G 20  -  90 81 2OnG 21  46,XY[11] 43 60 4O4G Tetraploid  View Large *O: LPL signal in orange , G: MYC signal in g reen . Figure 1. View large Download slide Kaplan Meier plots for OS and (A) 8p- and/or 8q+, (B) 8p- or (C) 8q+. Figure 1. View large Download slide Kaplan Meier plots for OS and (A) 8p- and/or 8q+, (B) 8p- or (C) 8q+.  Close modal Disclosures No relevant conflicts of interest to declare.",
    "topics": [
        "chromosomes, human, pair 8",
        "chronic b-cell leukemias",
        "chronic lymphocytic leukemia",
        "karyotype determination procedure",
        "karyotype 46, xx",
        "cytogenetics",
        "chromosomes",
        "conflict of interest",
        "disclosure",
        "precipitating factors"
    ],
    "author_names": [
        "Gonzalo Blanco",
        "Anna Puiggros",
        "Mar\u00eda Rodr\u00edguez-Rivera",
        "Carme Melero",
        "Mar\u00eda Dolores Garc\u00eda-Malo",
        "Rosa Collado, PhD",
        "Margarita Ortega, PhD",
        "Mar\u00eda Jos\u00e9 Calasanz, PhD",
        "Elisa Lu\u00f1o",
        "Mar\u00eda Teresa Vargas",
        "Javier Grau, MD",
        "Carolina Mart\u00ednez-Laperche, PhD",
        "Alberto Valiente",
        "Jos\u00e9 Cervera",
        "\u00c1ngeles Pi\u00f1\u00e1n",
        "Jose Mar\u00eda Hern\u00e1ndez-Rivas",
        "Ana Batlle",
        "Marta Salido",
        "Francisco Ortu\u00f1o",
        "M\u00aaTeresa Ardanaz",
        "Ana Ferrer",
        "David Ivars, PhD",
        "Alicia Rodriguez, MD",
        "Pau Abrisqueta, MD",
        "Blanca Espinet, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Gonzalo Blanco",
            "author_affiliations": [
                "Hospital del Mar, Barcelona, Spain ",
                "Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain ",
                "Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Anna Puiggros",
            "author_affiliations": [
                "Hospital del Mar, Barcelona, Spain ",
                "Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar\u00eda Rodr\u00edguez-Rivera",
            "author_affiliations": [
                "Molecular cytogenetics laboratory. Pathology Service, Hospital del Mar, Barcelona, Spain "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carme Melero",
            "author_affiliations": [
                "Molecular cytogenetics laboratory. Pathology Service, Hospital del Mar, Barcelona, Spain "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar\u00eda Dolores Garc\u00eda-Malo",
            "author_affiliations": [
                "Hematology Service, Hospital Universitario Morales Meseguer, Murcia, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosa Collado, PhD",
            "author_affiliations": [
                "Hematology Service, Hospital General Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Margarita Ortega, PhD",
            "author_affiliations": [
                "Cytogenetics Laboratory, Hematology Service, Hospital Vall d'Hebron, Barcelona, Spain "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar\u00eda Jos\u00e9 Calasanz, PhD",
            "author_affiliations": [
                "University of Navarra, Pamplona, Spain "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisa Lu\u00f1o",
            "author_affiliations": [
                "Hospital Universitario Central de Asturias, Oviedo, Spain "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar\u00eda Teresa Vargas",
            "author_affiliations": [
                "Hospital Universitario Virgen de la Macarena, Sevilla, Spain "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Javier Grau, MD",
            "author_affiliations": [
                "ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carolina Mart\u00ednez-Laperche, PhD",
            "author_affiliations": [
                "Hematology Service, Hospital Gregorio Mara\u00f1\u00f3n. Health Research Institute Gregorio Mara\u00f1\u00f3n., Madrid, Spain "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alberto Valiente",
            "author_affiliations": [
                "Genetics and Hematology Service, Hospital of Navarra, Pamplona, Spain "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jos\u00e9 Cervera",
            "author_affiliations": [
                "Genetics Unit, Hospital Universitario La Fe, Valencia, Spain "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "\u00c1ngeles Pi\u00f1\u00e1n",
            "author_affiliations": [
                "Hematology Service, Hospital de Cruces, Bilbao, Spain "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Mar\u00eda Hern\u00e1ndez-Rivas",
            "author_affiliations": [
                "Hematology Service, Hospital Universitario de Salamanca, IBSAL, IBMCC, Cancer Research Center, University of Salamanca, CSIC, Salamanca, Spain "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ana Batlle",
            "author_affiliations": [
                "Hematology Service, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Salido",
            "author_affiliations": [
                "Molecular cytogenetics laboratory. Pathology Service, Hospital del Mar, Barcelona, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francisco Ortu\u00f1o",
            "author_affiliations": [
                "Hospital Universitario Morales Meseguer, Centro Regional de Hemodonaci\u00f3n, IMIB-Arrixaca, Murcia, Spain "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "M\u00aaTeresa Ardanaz",
            "author_affiliations": [
                "Hematology Service, Hospital Txagorritxu, Vitoria, Spain"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ana Ferrer",
            "author_affiliations": [
                "Molecular cytogenetics laboratory. Pathology Service, Hospital del Mar, Barcelona, Spain "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "David Ivars, PhD",
            "author_affiliations": [
                "Hematology Service, Hospital General Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alicia Rodriguez, MD",
            "author_affiliations": [
                "Hospital Universitario Virgen de la Macarena, Sevilla, Spain "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pau Abrisqueta, MD",
            "author_affiliations": [
                "Cytogenetics Laboratory, Hematology Service, Hospital Vall d'Hebron, Barcelona, Spain "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Blanca Espinet, PhD",
            "author_affiliations": [
                "Hospital del Mar, Barcelona, Spain ",
                "Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-31T10:40:44",
    "is_scraped": "1"
}